HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoriko Yamashita-Kashima Selected Research

Intercellular Signaling Peptides and Proteins (Growth Factors)

1/2012Biomarkers for antitumor activity of bevacizumab in gastric cancer models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoriko Yamashita-Kashima Research Topics

Disease

11Neoplasms (Cancer)
06/2022 - 08/2011
5Breast Neoplasms (Breast Cancer)
11/2020 - 01/2012
5Stomach Neoplasms (Stomach Cancer)
01/2020 - 08/2011
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2022 - 01/2021
3Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2022 - 01/2021
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2023
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2019
1Carcinoma (Carcinomatosis)
04/2015
1Glioblastoma (Glioblastoma Multiforme)
01/2012
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2012
1Colorectal Neoplasms (Colorectal Cancer)
01/2012

Drug/Important Bio-Agent (IBA)

6Trastuzumab (Herceptin)FDA Link
11/2020 - 08/2011
5pertuzumabIBA
11/2020 - 08/2011
4human ERBB2 proteinIBA
11/2020 - 09/2013
4ErbB Receptors (EGF Receptor)IBA
01/2020 - 08/2011
3obinutuzumabIBA
06/2022 - 01/2021
3Ado-Trastuzumab EmtansineIBA
11/2020 - 09/2013
1polatuzumab vedotinIBA
08/2023
1Bendamustine HydrochlorideFDA Link
06/2022
1Prednisolone (Predate)FDA LinkGeneric
06/2022
1Paclitaxel (Taxol)FDA LinkGeneric
01/2020
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
10/2017
1Docetaxel (Taxotere)FDA Link
10/2017
1Drug CombinationsIBA
10/2017
1ParaffinIBA
10/2014
1Formaldehyde (Formol)FDA Link
10/2014
1Biomarkers (Surrogate Marker)IBA
01/2012
1Bevacizumab (Avastin)FDA Link
01/2012
1Monoclonal AntibodiesIBA
01/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012
1Angiogenesis Inducing Agents (Angiogenesis Factor)IBA
01/2012
1AntibodiesIBA
08/2011

Therapy/Procedure

6Therapeutics
11/2020 - 08/2011
3Retreatment
06/2022 - 01/2021
1Aftercare (After-Treatment)
06/2022
1Drug Therapy (Chemotherapy)
01/2021